merged_colon-cancer-blood-test-shield.txt
<question_number>1</question_number>
<answer>It has a poor record of finding precancerous growths.</answer>

<question_number>2</question_number>
<answer>colonoscopy</answer>

<question_number>3</question_number>
<answer>It requires only a sample of blood, which is easier to obtain than a colonoscopy or a fecal sample.</answer>

<question_number>4</question_number>
<answer>Its inability to detect precancerous growths effectively.</answer>

<question_number>5</question_number>
<answer>The FDA advisory committee recommended approval because it may prompt people who forget or avoid colorectal cancer screening to be screened.</answer>

<question_number>6</question_number>
<answer>It can detect early-stage cancers but has a poor record of finding precancerous growths.</answer>

<question_number>7</question_number>
<answer>Its inability to detect precancerous growths effectively.</answer>

<question_number>8</question_number>
<answer>It can detect early-stage cancers but has a poor record of finding precancerous growths.</answer>

<question_number>9</question_number>
<answer>It has a poor record of finding precancerous growths.</answer>

<question_number>10</question_number>
<answer>Because it may prompt people who forget or avoid colorectal cancer screening to be screened.</answer>